Comparing different measures of retention in outpatient HIV care

AIDS

Volumn 26, Issue 9, 2012, Pages 1131-1139

  Yehia, Baligh R ^a   Fleishman, John A ^b   Metlay, Joshua P ^a   Korthuis, P Todd ^c   Agwu, Allison L ^d   Berry, Stephen A ^d   Moore, Richard D ^d   Gebo, Kelly A ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

engagement in care; HIV outpatient care; HIV quality improvement; performance measures; retention in care; retention measures

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; DEMOGRAPHY; ETHNICITY; FEMALE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MEDICAID; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE FACTORS; AMBULATORY CARE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84861531934     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283528afa     Document Type: Article

References (34)

1. Mugavero MJ. Improving engagement in HIV care: what can we do? Top HIV Med 2008; 16:156-161.
2. Horstmann E, Brown J, Islam F, Buck J, Agins BD. Retaining HIV-infected patients in care: where are we? Where do we go from here?. Clin Infect Dis 2010; 50:752-761.
3. Ulett KB, Willig JH, Lin HY, Routman JS, Abroms S, Allison J, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS 2009; 23:41-49.
4. Berg MB, Safren SA, Mimiaga MJ, Grasso C, Boswell S, Mayer KH. Nonadherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic. AIDS Care 2005; 17:902-907.
5. Giordano TP, White AC Jr, Sajja P, Graviss EA, Arduino RC, Adu-Oppong A, et al. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr 2003; 32:399-405.
6. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med 1999; 131:81-87.
7. Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis 2003; 37:1112-1118.
8. Giordano TP, Gifford AL, White AC Jr, Suarez-Almazor ME, Rabeneck L, Hartman C, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis 2007; 44:1493-1499.
9. Mugavero MJ, Lin HY, Willig JH, Westfall AO, Ulett KB, Routman JS, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis 2009; 48:248-256.
10. Metsch LR, Pereyra M, Messinger S, Del Rio C, Strathdee SA, Anderson-Mahoney P, et al. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis 2008; 47:577-584.
11. Arici C, Ripamonti D, Maggiolo F, Rizzi M, Finazzi MG, Pezzotti P, et al. Factors associated with the failure of HIVpositive persons to return for scheduled medical visits. HIV Clin Trials 2002; 3:52-57.
12. Yehia BR, Fleishman JA, Hicks PL, Ridore M, Moore RD, Gebo KA. Inpatient health services utilization among HIV-infected adult patients in care 2002-2007. J Acquir Immune Defic Syndr 2010; 53:397-404.
13. Yehia B, Frank I. Battling AIDS in America: an evaluation of the National HIV/AIDS strategy. Am J Public Health 2011; 101:e4-e8.
14. The White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States. Washington, DC: White House Office of National AIDS Policy; 2010.
15. Mugavero MJ, Davila JA, Nevin CR, Giordano TP. From access to engagement: measuring retention in outpatient HIV clinical care. AIDS Patient Care STDS 2010; 24:607-613.
16. Olatosi BA, Probst JC, Stoskopf CH, Martin AB, Duffus WA. Patterns of engagement in care by HIV-infected adults: South Carolina, 2004-2006. AIDS 2009; 23:725-730.
17. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011; 52:793-800.
18. Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS 2010; 24:2665-2678.
19. Bozzette SA, Berry SH, Duan N, Frankel MR, Leibowitz AA, Lefkowitz D, et al. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med 1998; 339:1897-1904.
20. Torian LV, Wiewel EW. Continuity of HIV-related medical care, New York City, 2005-2009: do patients who initiate care stay in care? AIDS Patient Care STDS 2011; 25:79-88.
21. Health Resources Services Administration. HAB HIV Core Clinical Performance Measures for Adult/Adolescent Clients: Group 1-Medical Visits. 2008.
22. Chesney MA. The elusive gold standard. Future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr 2006; 43 (Suppl 1):S149-S155.
23. Yehia BR, Gebo KA, Hicks PB, Korthuis PT, Moore RD, Ridore M, et al. Structures of care in the clinics of the HIV Research Network. AIDS Patient Care STDS 2008; 22:1007-1013.
24. Howe CJ, Cole SR, Napravnik S, Eron JJ. Enrollment, retention, and visit attendance in the University of North Carolina Center for AIDS Research HIV clinical cohort, 2001-2007. AIDS Res Hum Retroviruses 2010; 26:875-881.
25. Lanoy E, Mary-Krause M, Tattevin P, Dray-Spira R, Duvivier C, Fischer P, et al. Predictors identified for losses to follow-up among HIV-seropositive patients. J Clin Epidemiol 2006; 59:829-835.
26. Schepens T, Morreel S, Florence E, Koole O, Colebunders R. Incidence and risk factors associated with lost to follow-up in a Belgian cohort of HIV-infected patients treated with highly active antiretroviral therapy. Int J STD AIDS 2010; 21:765-769.
27. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989; 45:255-268.
28. Vital Signs. HIV prevention through care and treatment: United States. Morb Mortal Wkly Rep 2011; 60:1618-1623.
29. Hall IH MK, Tang T, Li J, Johnson AS, Shouse L. Retention in care of HIV-infected adults and adolescents in 13 U.S. areas. Presented at the National HIV Prevention Conference. Atlanta, GA; August 14-17, 2011.
30. Cabral HJ, Tobias C, Rajabiun S, Sohler N, Cunningham C, Wong M, et al. Outreach program contacts: do they increase the likelihood of engagement and retention in HIV primary care for hard-to-reach patients? AIDS Patient Care STDS 2007; 21 (Suppl 1):S59-S67.
31. Catz SL, McClure JB, Jones GN, Brantley PJ. Predictors of outpatient medical appointment attendance among persons with HIV. AIDS Care 1999; 11:361-373.
32. Tripathi A, Youmans E, Gibson JJ, Duffus WA. The impact of retention in early HIV medical care on viro-immunological parameters and survival: a statewide study. AIDS Res Hum Retroviruses 2011; 27:751-758.
33. Rajabiun S, Mallinson RK, McCoy K, Coleman S, Drainoni ML, Rebholz C, et al. Getting me back on track': the role of outreach interventions in engaging and retaining people living with HIV/AIDS in medical care. AIDS Patient Care STDS 2007; 21 (Suppl 1):S20-S29.
34. Magnus M, Jones K, Phillips G 2nd, Binson D, Hightow-Weidman LB, Richards-Clarke C, et al. Characteristics associated with retention among African American and Latino adolescent HIV-positive men: results from the outreach, care, and prevention to engage HIV-seropositive young MSM of color special project of national significance initiative. J Acquir Immune Defic Syndr 2010; 53:529-536.